Seasonal Affective Disorder: The Evidence-Based Supplement Protocol
Seasonal affective disorder (SAD) is recurrent winter-pattern major depressive episodes. Bright light therapy (10,000 lux for 30 minutes morning) is the foundational intervention with the strongest evidence — comparable in effect size to SSRIs for the seasonal pattern. Supplements have an adjunctive role.
Vitamin D — Repletion to 30+ ng/mL
Vitamin D status correlates with mood in SAD cohorts and many patients are deficient by midwinter. Repletion improves mood in deficient SAD patients but does not consistently outperform placebo in already-replete adults. Test and treat. See vitamin D piece.
Light Therapy — The Gold Standard
Not a supplement but the highest-evidence intervention. 10,000 lux full-spectrum light box for 20–30 minutes within 1 hour of waking, daily from autumn through spring. Effect size comparable to SSRIs. Mention here because any supplement protocol for SAD that omits light therapy is fundamentally incomplete.
EPA-Dominant Omega-3, 1–2 g EPA Daily
Omega-3 has positive evidence in depressive disorders broadly. SAD-specific trials are smaller but consistent with the broader signal. See omega-3 depression piece.
Saffron, 30 mg Daily
Saffron has antidepressant evidence in non-seasonal MDD; SAD-specific data is more limited. Reasonable adjunct in mild-moderate seasonal symptoms. See saffron piece.
Melatonin — Phase-Shifting, Not Mood
Low-dose melatonin (0.3 mg afternoon) has been studied for phase-shifting circadian timing in SAD. Not a mood intervention per se but addresses one mechanistic component. See melatonin dosing piece.
What NOT to Take
Avoid St. John's Wort + SSRIs simultaneously — serotonin syndrome risk. Skip "winter blues formula" megaproducts with subclinical doses. Avoid 5-HTP if on any serotonergic medication. Don't replace SSRI or light therapy with supplements in moderate-severe SAD.
How to Run the Protocol
Bright light therapy 10,000 lux × 30 min morning, daily Oct–April. Vitamin D to repletion. Omega-3 1.5 g EPA daily. Outdoor time, even on overcast days (outdoor "cloudy day" light still exceeds indoor by 10×). If symptoms remain moderate-severe, SSRI (bupropion XL has the only FDA SAD-specific indication) or psychiatry referral. See SAD condition page.
Sources
- Lam RW, Levitt AJ, Levitan RD, et al. "Efficacy of bright light treatment, fluoxetine, and the combination in patients with nonseasonal major depressive disorder." JAMA Psychiatry, 2016;73(1):56-63. PMID: 26580307. DOI: 10.1001/jamapsychiatry.2015.2235.
- Nussbaumer-Streit B, Forneris CA, Morgan LC, et al. "Light therapy for preventing seasonal affective disorder." Cochrane Database Syst Rev, 2019;3:CD011269. PMID: 30883673. DOI: 10.1002/14651858.CD011269.pub3.
- Stewart AE, Roecklein KA, Tanner S, Kimlin MG. "Possible contributions of skin pigmentation and vitamin D in a polyfactorial model of seasonal affective disorder." Medical Hypotheses, 2014;83(5):517-525. PMID: 25270233. DOI: 10.1016/j.mehy.2014.09.010.
- Mocking RJT, Harmsen I, Assies J, Koeter MWJ, Ruhé HG, Schene AH. "Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder." Translational Psychiatry, 2016;6(3):e756. PMID: 26978738. DOI: 10.1038/tp.2016.29.
- Rohan KJ, Mahon JN, Evans M, et al. "Randomized trial of cognitive-behavioral therapy versus light therapy for seasonal affective disorder." American Journal of Psychiatry, 2015;172(9):862-869. PMID: 25859764. DOI: 10.1176/appi.ajp.2015.14101293.